Sun Pharmaceutical Industries Ltd.

Sun Pharmaceutical Industries’ Mohali plant in Punjab has received Official Action Indicated (OAI) classification from United States Food and Drug Administration (USFDA). The Company continues to manufacture and distribute existing products for the US market, thereby not likely to have any material adverse impact on current business from the facility.

The company continues to cooperate with the USFDA and will undertake all necessary steps to resolve these issues and to ensure that the regulator is completely satisfied with the Company’s remedial action. Sun Pharma remains committed to being cGMP compliant and in supplying high-quality products to its customers and patients globally. The plant was inspected in August and had received a form 483 with six observations earlier.

Sun Pharmaceutical Industries is the world's fourth largest specialty generic pharmaceutical company and India's top pharmaceutical company.